<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009444/" ref="ordinalpos=3377&amp;ncbi_uid=6107664&amp;link_uid=PMC4009444" image-link="/pmc/articles/PMC4009444/figure/F2/" class="imagepopup">FIGURE 2.  From: Hepcidin antagonists for potential treatments of disorders with hepcidin excess. </a></div><br /><div class="p4l_captionBody"><b>Intracellular signaling pathways for hepcidin expression. (A)</b> Iron status stimulates hepcidin expression through BMP6 and Holo-Tf. This signaling involves BMP receptor, HJV (BMPco-receptor), TMPRSS6 (MT2, a negative regulator), Neogenin, TfR2, and HFE (sensors of Holo-Tf saturation). Intracellularly this multiprotein complex triggers the activation of SMAD1/5/8 and SMAD4 components and possibly ERK1/2. <b>(B)</b> The inflammatory status triggers the hepcidin expression through IL6/STAT3 pathway and ActivinB that activates SMAD1/5/8 pathway.</div></div>